Mayne Pharma Group Limited

ASX:MYX Stock Report

Market Cap: AU$385.5m

Mayne Pharma Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

ASX:MYX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Nov 24BuyAU$554,081The Vanguard Group, Inc.Company130,113AU$4.88
17 Oct 24BuyAU$7,149,887MLC Investments LimitedCompany1,579,910AU$4.53
15 Oct 24SellAU$1,017,809IOOF Investment Management LimitedCompany150,414AU$7.15
10 Oct 24SellAU$1,552,093MLC Investments LimitedCompany347,961AU$4.46
30 Aug 24BuyAU$373,976IOOF Investment Management LimitedCompany90,540AU$4.14
25 Jun 24SellAU$129,086OnePath Funds Management LimitedCompany28,667AU$4.50
14 Mar 24BuyAU$1,510,903UBS Asset Management AGCompany217,138AU$6.96
14 Mar 24SellAU$2,163,028UBS Asset Management AGCompany311,656AU$6.94
08 Mar 24BuyAU$191,458UBS Asset Management AGCompany27,522AU$7.00
08 Mar 24SellAU$322,565UBS Asset Management AGCompany46,490AU$6.97
07 Mar 24BuyAU$2,780,597UBS Asset Management AGCompany399,486AU$6.96
07 Mar 24BuyAU$310,974Credit Suisse Asset Management (Switzerland) Ltd.Company44,430AU$7.00
07 Mar 24SellAU$3,934,045UBS Asset Management AGCompany567,908AU$6.93
01 Mar 24BuyAU$5,234,010UBS Asset Management AGCompany797,712AU$6.56
01 Mar 24SellAU$4,429,142UBS Asset Management AGCompany673,765AU$6.57
26 Feb 24BuyAU$2,768,159UBS Asset Management AGCompany459,566AU$6.02
26 Feb 24SellAU$1,360,858UBS Asset Management AGCompany227,471AU$5.98
23 Feb 24BuyAU$36,512,464UBS Asset Management AGCompany6,915,901AU$5.28
23 Feb 24SellAU$32,701,025UBS Asset Management AGCompany6,192,570AU$5.28

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MYX?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms6,085,2817.5%
Individual Insiders7,055,7668.69%
Private Companies7,227,9778.91%
Institutions25,674,53531.6%
General Public35,104,40043.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 56.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.5%
Viburnum Funds Pty Ltd.
6,085,281AU$28.9m-5.34%6.43%
6.52%
Bruce Mathieson
5,292,066AU$25.1m0%no data
6.39%
Bmgbj Myx Pty Ltd
5,183,477AU$24.6m0%no data
5.93%
Goldman Sachs Group, Investment Banking and Securities Investments
4,810,445AU$22.8m-7.81%0.01%
5.23%
Lazard Asset Management LLC
4,240,774AU$20.1m0%0.01%
5.11%
The Vanguard Group, Inc.
4,148,229AU$19.7m1.27%no data
4.28%
MLC Investments Limited
3,472,721AU$16.5m173%3.8%
2.48%
Dimensional Fund Advisors LP
2,013,402AU$9.6m-0.98%no data
2.33%
UBS Asset Management AG
1,889,905AU$9.0m0%no data
2.1%
Credit Suisse Funds AG
1,701,480AU$8.1m0%0.09%
0.99%
Investors Mutual Limited
800,000AU$3.8m0%1.12%
0.99%
IVL Group Pty Ltd
800,000AU$3.8m0%no data
0.66%
IOOF Investment Management Limited
538,532AU$2.6m0%0.08%
0.64%
Roger Corbett
522,028AU$2.5m0%no data
0.63%
Y S Chains Pty Ltd
510,000AU$2.4m2%no data
0.63%
Zhang Yunsong
510,000AU$2.4m70%no data
0.52%
Kon Tzimokas
420,000AU$2.0m5%no data
0.51%
Norges Bank Investment Management
413,308AU$2.0m0%no data
0.47%
Birbal Investments Pty Ltd
380,000AU$1.8m26.7%no data
0.46%
Australian Super Pty Ltd
374,563AU$1.8m0%no data
0.44%
Wal Assets Pty Ltd
354,500AU$1.7m0%no data
0.42%
Blackstone Inc.
341,518AU$1.6m0%no data
0.39%
Blackstone Alternative Asset Management L.P.
314,685AU$1.5m0%0.21%
0.31%
OnePath Funds Management Limited
248,106AU$1.2m0%0.49%
0.18%
Charles Schwab Investment Management, Inc.
149,149AU$708.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 22:56
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mayne Pharma Group Limited is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightAPP Securities Pty Ltd.
Russell WrightBarclay Pearce Capital Pty Limited
John HesterBell Potter